About EazyScripts
EazyScripts is a company based in Chicago (United States) founded in 2014. EazyScripts has raised $1.5 million across 1 funding round from investors including Bluff Point Associates. EazyScripts offers products and services including ePrescribing Platform. EazyScripts operates in a competitive market with competitors including Pharmacierge, WonDRx, SimboAlpha, Prescriby and EirSystems, among others.
- Headquarter Chicago, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eazyscripts Technology, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.5 M (USD)
in 1 rounds
-
Latest Funding Round
$1.5 M (USD), Series A
Aug 02, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EazyScripts
EazyScripts offers a comprehensive portfolio of products and services, including ePrescribing Platform.
Enables electronic prescribing for telehealth with quick script tools.
Funding Insights of EazyScripts
EazyScripts has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.5 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EazyScripts
EazyScripts has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bluff Point Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for EazyScripts
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EazyScripts
Investment portfolio details for EazyScripts
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EazyScripts
Detailed financials for EazyScripts
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eazyscripts Comparisons
Peer comparison for EazyScripts
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EazyScripts
EazyScripts operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmacierge, WonDRx, SimboAlpha, Prescriby and EirSystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medication management software is provided for doctors and patients.
|
|
| Locked | Locked | Locked |
EHR facilitator solutions are provided for healthcare professionals' record management.
|
|
| Locked | Locked | Locked |
AI-based EMR management is offered to healthcare professionals.
|
|
| Locked | Locked | Locked |
Prescription management software is provided for healthcare professionals.
|
|
| Locked | Locked | Locked |
Blockchain-based prescription management software is provided by EirSystems.
|
Detailed competitors of EazyScripts
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eazyscripts
Complete news archive for EazyScripts
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EazyScripts
EazyScripts was founded in 2014 and raised its 1st funding round 3 years after it was founded.
EazyScripts is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
EazyScripts is a funded company, having raised a total of $1.5M across 1 funding round to date.
EazyScripts was founded in 2014 in Chicago, United States, focusing on the health IT sector. Electronic prescribing solutions are integrated with Health IT systems to enable prescription submissions, fill data checks, and secure prior authorizations. Medication adherence features are included to support patient and provider needs. The platform is adapted for use on desktops, laptops, tablets, and smartphones, while prescription drug monitoring programs are offered to aid controlled substance management.
EazyScripts's top competitors include EirSystems, Pharmacierge and SimboAlpha.
EazyScripts offers ePrescribing Platform.
EazyScripts has 1 investor. Key investors include Bluff Point Associates.